Article Information
History
- June 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Robert F. Hillary1,
- Danni A. Gadd1,
- Daniel L. McCartney1,
- Liu Shi2,
- Archie Campbell1,
- Rosie M. Walker1,3,
- Craig W. Ritchie4,
- Ian J. Deary5,
- Kathryn L. Evans1,
- Alejo J. Nevado-Holgado2,
- Caroline Hayward6,
- David J. Porteous1,
- Andrew M. McIntosh1,7,
- Simon Lovestone2,8,
- Matthew R. Robinson9 and
- Riccardo E. Marioni1,*
- 1Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU, Edinburgh, UK
- 2Department of Psychiatry, University of Oxford, OX3 7JX, Oxford, UK
- 3Centre for Clinical Brain Sciences, Chancellor’s Building, 49 Little France Crescent, University of Edinburgh, EH16 4SB, Edinburgh, UK
- 4Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, University of Edinburgh, EH16 4UX, Edinburgh, UK
- 5Lothian Birth Cohorts, Department of Psychology, University of Edinburgh, EH8 9JZ, Edinburgh, UK
- 6MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU, Edinburgh, UK
- 7Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, EH16 4UX, Edinburgh, UK
- 8Johnson and Johnson Medical Ltd, Wokingham, RG40 3EW, UK
- 9Institute of Science and Technology Austria, Am Campus 1, Klosterneuburg, Austria
- ↵* corresponding author: riccardo.marioni{at}ed.ac.uk
Posted June 10, 2021.
Genome and epigenome wide studies of plasma protein biomarkers for Alzheimer’s disease implicate TBCA and TREM2 in disease risk
